Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2012 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Long-term efficacy and safety of dichlorphenamide for treatment of primary periodic paralysis.
Muscle Nerve. 2021 Sep;64(3):342-346. doi: 10.1002/mus.27354. Epub 2021 Jul 9.
Muscle Nerve. 2021.
PMID: 34129236
Free PMC article.
Clinical Trial.
Unintended effects of orphan product designation for rare neurological diseases.
Murphy SM, Puwanant A, Griggs RC; Consortium for Clinical Investigations of Neurological Channelopathies (CINCH) and Inherited Neuropathies Consortium (INC) Consortia of the Rare Disease Clinical Research Network.
Murphy SM, et al.
Ann Neurol. 2012 Oct;72(4):481-90. doi: 10.1002/ana.23672.
Ann Neurol. 2012.
PMID: 23109143
Free PMC article.
Review.
Item in Clipboard
Pivotal studies of orphan drugs approved for neurological diseases.
Mitsumoto J, Dorsey ER, Beck CA, Kieburtz K, Griggs RC.
Mitsumoto J, et al.
Ann Neurol. 2009 Aug;66(2):184-90. doi: 10.1002/ana.21676.
Ann Neurol. 2009.
PMID: 19743448
Free PMC article.
Item in Clipboard
Cite
Cite